Abbott Laboratories
ABT
$102.62
Share price
-1.10%
Change (1 day)
-11.85%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total debt
Total debt on the balance sheet as of December 2022 : $17.71 B
According to Abbott Laboratories's latest financial reports the company's total debt is $17.71 B. A company’s total debt is the sum of all current and non-current debts.
Abbott Laboratories - Total debt on balance sheet (from 2001 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $17.71 B | -6.79% |
| 2021-12-31 | $19.00 B | -3.27% |
| 2020-12-31 | $19.64 B | 4% |
| 2019-12-31 | $18.89 B | -3.43% |
| 2018-12-31 | $19.56 B | -29.93% |
| 2017-12-31 | $27.92 B | 26.89% |
| 2016-12-31 | $22.00 B | 144.48% |
| 2015-12-31 | $9.00 B | 14.74% |
| 2014-12-31 | $7.84 B | 19.57% |
| 2013-12-31 | $6.56 B | -67.96% |
| 2012-12-31 | $20.47 B | 32.84% |
| 2011-12-31 | $15.41 B | -18.52% |
| 2010-12-31 | $18.91 B | 14.96% |
| 2009-12-31 | $16.45 B | 43.78% |
| 2008-12-31 | $11.44 B | -6.29% |
| 2007-12-31 | $12.21 B | -1.59% |
| 2006-12-31 | $12.41 B | 87.09% |
| 2005-12-31 | $6.63 B | -2.17% |
| 2004-12-31 | $6.78 B | 13.2% |
| 2003-12-31 | $5.98 B | -6.74% |
| 2002-12-31 | $6.42 B | -11.88% |
| 2001-12-31 | $7.28 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $39.65 B | 123.86% | 🇺🇸 USA |
 Novartis NVS | $29.20 B | 64.85% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.87 B | 96.83% | 🇺🇸 USA |
 Medtronic MDT | $28.12 B | 58.77% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $35.25 B | 99.01% | 🇺🇸 USA |
 Boston Scientific BSX | $9.28 B | -47.61% | 🇺🇸 USA |
 Hologic HOLX | $2.82 B | -84.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $39.37 B | 122.23% | 🇺🇸 USA |
 AstraZeneca AZN | $31.50 B | 77.82% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $25.89 B | 46.17% | 🇬🇧 UK |